Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia

BACKGROUND: Methotrexate (MTX) eradicates leukemic cells by disrupting de novo nucleotide biosynthesis and DNA replication, resulting in cell death. Since its introduction in 1947, MTX-containing chemotherapeutic regimens have proven instrumental in achieving curative effects in acute lymphoblastic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wojtuszkiewicz, Anna, Peters, Godefridus J., van Woerden, Nicole L., Dubbelman, Boas, Escherich, Gabriele, Schmiegelow, Kjeld, Sonneveld, Edwin, Pieters, Rob, van de Ven, Peter M., Jansen, Gerrit, Assaraf, Yehuda G., Kaspers, Gertjan J. L., Cloos, Jacqueline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455979/
https://www.ncbi.nlm.nih.gov/pubmed/26022503
http://dx.doi.org/10.1186/s13045-015-0158-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455979/
https://www.ncbi.nlm.nih.gov/pubmed/26022503
http://dx.doi.org/10.1186/s13045-015-0158-9

Ejemplares similares